SMAD4
“Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer”. World Journal of Gastroenterology 13 (27): 3714–20. (Jul 2007). doi:10.3748/wjg.v13.i27.3714. PMC 4250643. PMID 17659731. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4250643/.
“Smad4-independent, PP2A-dependent apoptotic effect of exogenous transforming growth factor beta 1 in lymphoma cells”. Experimental Cell Research 313 (15): 3167–74. (Sep 2007). doi:10.1016/j.yexcr.2007.05.028. PMID 17643425.
(Apr 2007). PMC 2080529. PMID 17436386. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2080529/.
“Loss of Smad4 expression predicts liver metastasis in human colorectal cancer”. Oncology Reports 17 (5): 1095–9. (May 2007). doi:10.3892/or.17.5.1095. PMID 17390050.
“Smad4 is critical for self-renewal of hematopoietic stem cells”. The Journal of Experimental Medicine 204 (3): 467–74. (Mar 2007). doi:10.1084/jem.20060465. PMC 2137898. PMID 17353364. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2137898/.
“Smad4 is essential for down-regulation of E-cadherin induced by TGF-beta in pancreatic cancer cell line PANC-1”. Journal of Biochemistry 141 (3): 345–51. (Mar 2007). doi:10.1093/jb/mvm039. PMID 17301079.